Jason Breaux Buys 5,000 Shares of Crescent Capital BDC (NASDAQ:CCAP) Stock

Posted by Geri Gentry on May 23rd, 2026

Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) CEO Jason Breaux acquired 5,000 shares of the business’s stock in a transaction dated Wednesday, May 20th. The stock was acquired at an average price of $11.19 per share, for a total transaction of $55,950.00. Following the completion of the transaction, the chief executive officer owned 52,636 shares in the company, valued at approximately $588,996.84. The trade was a 10.50% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Crescent Capital BDC Price Performance

Shares of CCAP stock opened at $11.37 on Friday. The firm has a market cap of $418.98 million, a P/E ratio of 27.73 and a beta of 0.59. Crescent Capital BDC, Inc. has a fifty-two week low of $10.92 and a fifty-two week high of $16.03. The business’s 50 day moving average price is $12.76 and its 200-day moving average price is $13.65. The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.53 and a current ratio of 1.53.

Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last issued its quarterly earnings data on Wednesday, May 13th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The firm had revenue of ($6.84) million for the quarter, compared to analyst estimates of $39.58 million. Crescent Capital BDC had a return on equity of 9.34% and a net margin of 9.26%. On average, equities research analysts anticipate that Crescent Capital BDC, Inc. will post 1.39 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The firm also recently disclosed a special dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 30th will be given a $0.03 dividend. This represents a dividend yield of 107.0%. The ex-dividend date is Monday, November 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 409.76%.

Institutional Trading of Crescent Capital BDC

Hedge funds have recently made changes to their positions in the stock. Alpine Global Management LLC bought a new stake in shares of Crescent Capital BDC in the 3rd quarter worth approximately $3,137,000. Bulldog Investors LLP raised its holdings in Crescent Capital BDC by 50.7% in the 3rd quarter. Bulldog Investors LLP now owns 437,518 shares of the company’s stock worth $6,239,000 after acquiring an additional 147,135 shares during the last quarter. ICG Advisors LLC purchased a new position in Crescent Capital BDC in the 4th quarter worth approximately $1,284,000. Riverbridge Partners LLC purchased a new position in Crescent Capital BDC in the 4th quarter worth approximately $1,326,000. Finally, Adams Asset Advisors LLC raised its holdings in Crescent Capital BDC by 352.6% in the 4th quarter. Adams Asset Advisors LLC now owns 79,828 shares of the company’s stock worth $1,122,000 after acquiring an additional 62,189 shares during the last quarter. 49.46% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wall Street Zen lowered Crescent Capital BDC from a “hold” rating to a “sell” rating in a research report on Saturday, May 16th. LADENBURG THALM/SH SH lowered their price objective on shares of Crescent Capital BDC from $16.00 to $15.00 and set a “buy” rating for the company in a report on Friday, May 15th. B. Riley Financial restated a “neutral” rating on shares of Crescent Capital BDC in a report on Friday, May 15th. Oppenheimer lowered shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $19.00 to $16.00 in a report on Friday, May 15th. Finally, Zacks Research lowered shares of Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a report on Monday, May 18th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $14.30.

Read Our Latest Stock Analysis on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.